Shareable Research Card

MERRIMACK PHARMACEUTICALS INC Entity Common Stock, Shares Outstanding

This metric view shows MERRIMACK PHARMACEUTICALS INC entity common stock, shares outstanding history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q1 2024
Latest reported value
14,531,760

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Open stable link Open company facts

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 15 Mar 2024
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q1 2024.
  • Latest reported value on this page: 14,531,760.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Create account to save this filer Open company facts

Latest update

Latest update for Entity Common Stock, Shares Outstanding

New fact period available

Latest reported entity common stock, shares outstanding: 14,531,760. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

15 Mar 2024

Page type

Metric history

Latest period

Q1 2024

SEC-backed company facts were refreshed from filings filed on 15 May 2024.

Open recent updates hub Open company facts

Benchmark Context

How Entity Common Stock, Shares Outstanding compares with peers

MERRIMACK PHARMACEUTICALS INC is outside the visible top 120 companies for entity common stock, shares outstanding in the current sample.

Compared with

Compared with 120 companies reporting entity common stock, shares outstanding in shares. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Entity Common Stock, Shares Outstanding is up about 1.9% versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Dec 2019 to 14 May 2026.
  • Nearby companies in this sample: WORLD HEALTH ENERGY HOLDINGS, INC. and Healthier Choices Management Corp..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Open company facts

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Financial Metric Page

MERRIMACK PHARMACEUTICALS INC: Entity Common Stock, Shares Outstanding

Latest period: Q1 2024. Period end: 15 Mar 2024. Units: shares. Frequency: quarterly.

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

What This Metric Tells You

  • Shows the reported level of entity common stock, shares outstanding over 30 Apr 2012 - 15 Mar 2024.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 38 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Entity Common Stock, Shares Outstanding levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 WORLD HEALTH ENERGY HOLDINGS, INC. (when) 550,834,347,495 Instant - 19 Nov 2025 Open WORLD HEALTH ENERGY HOLDINGS, INC. Entity Common Stock, Shares Outstanding
2 Healthier Choices Management Corp. (hcmc) 527,156,418,606 Instant - 27 Mar 2026 Open Healthier Choices Management Corp. Entity Common Stock, Shares Outstanding
3 BANCO SANTANDER CHILE (bsac) 188,446,126,794 Instant - 31 Dec 2025 Open BANCO SANTANDER CHILE Entity Common Stock, Shares Outstanding
4 BANK OF CHILE (bch) 101,017,081,114 Instant - 31 Dec 2025 Open BANK OF CHILE Entity Common Stock, Shares Outstanding
5 Eason Technology Ltd (dxf) 93,677,555,803 Instant - 31 Dec 2025 Open Eason Technology Ltd Entity Common Stock, Shares Outstanding
6 Akari Therapeutics Plc (aktx) 91,567,009,533 Instant - 01 Mar 2026 Open Akari Therapeutics Plc Entity Common Stock, Shares Outstanding

Metric Details

Metric
Entity Common Stock, Shares Outstanding (EntityCommonStockSharesOutstanding)
Taxonomy
dei
Units tracked
shares
Frequency coverage
quarterly
History range
30 Apr 2012 - 15 Mar 2024
Facts on this page
38
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

MERRIMACK PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 14,531,760 +276,656 +1.9% 15 Mar 2024 10-K/A 21 Mar 2024 2023 FY
Q3 2023 14,320,953 +910,710 +6.8% 31 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 14,320,953 +910,710 +6.8% 01 Aug 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 14,255,104 +844,861 +6.3% 07 Mar 2023 10-K 09 Mar 2023 2022 FY
Q3 2022 13,410,243 0 0% 01 Nov 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 13,410,243 0 0% 02 Aug 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 13,410,243 0 0% 07 Mar 2022 10-K 09 Mar 2022 2021 FY
Q3 2021 13,410,243 +30,000 +0.22% 02 Nov 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 13,410,243 +30,000 +0.22% 02 Aug 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 13,410,243 +30,000 +0.22% 08 Mar 2021 10-K 10 Mar 2021 2020 FY
Q3 2020 13,380,243 +17,292 +0.13% 02 Nov 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 13,380,243 +30,422 +0.23% 03 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 13,380,243 +37,459 +0.28% 08 Mar 2020 10-K 12 Mar 2020 2019 FY
Q3 2019 13,362,951 +20,167 +0.15% 08 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 13,349,821 +7,037 +0.05% 10 Jul 2019 10-Q 17 Jul 2019 2019 Q2
Q1 2019 13,342,784 0 0% 27 Feb 2019 10-K 06 Mar 2019 2018 FY
Q3 2018 13,342,784 +9,817 +0.07% 01 Nov 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 13,342,784 -119,450,472 -90% 02 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 13,342,784 -119,085,137 -90% 07 Mar 2018 10-K 12 Mar 2018 2017 FY
Q3 2017 13,332,967 -116,282,977 -90% 07 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 132,793,256 +3,552,460 +2.7% 08 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 132,427,921 +4,702,791 +3.7% 09 May 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 129,615,944 +14,041,815 +12% 04 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 129,240,796 +17,821,670 +16% 29 Jul 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 127,725,130 +17,700,792 +16% 27 Apr 2016 10-Q 02 May 2016 2016 Q1
Q3 2015 115,574,129 +9,689,991 +9.2% 31 Oct 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 111,419,126 +6,831,539 +6.5% 31 Jul 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 110,024,338 +6,619,187 +6.4% 30 Apr 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 106,934,746 13 Feb 2015 10-K 27 Feb 2015 2014 FY
Q3 2014 105,884,138 +3,536,614 +3.5% 31 Oct 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 104,587,587 +2,377,958 +2.3% 31 Jul 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 103,405,151 +7,317,231 +7.6% 30 Apr 2014 10-Q 06 May 2014 2014 Q1
Q3 2013 102,347,524 +8,166,105 +8.7% 31 Oct 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 102,209,629 +8,490,635 +9.1% 31 Jul 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 96,087,920 +2,787,959 +3% 30 Apr 2013 10-Q 13 May 2013 2013 Q1
Q3 2012 94,181,419 31 Oct 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 93,718,994 31 Jul 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 93,299,961 30 Apr 2012 10-Q 15 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .